XML 66 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
 9 Months Ended 12 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Dec. 31, 2016
Dec. 31, 2015
Cash flows from operating activities:        
Net loss $ (2,355,925) $ (3,902,525) $ (5,571,083) $ (2,027,498)
Adjustments to reconcile net loss to net cash provided by operating activities:        
Depreciation and amortization from continuing operations     10,256,185 7,784,917
Depreciation and amortization 7,346,640 7,723,372 10,256,185 7,784,917
Depreciation and amortization from discontinued operations       165,646
Stock compensation 410,760 388,602 520,578 464,827
Bad debt expense 37,205 (54,405) (196) 236,329
Gain on sale of real estate assets, net (2,237,423) (2,121,453) (2,186,481) (6,243,640)
Impairment of real estate assets   700,000 948,053 0
Amortization of financing costs 956,956 1,081,520 1,447,021 1,286,437
Amortization of above-market leases 79,013 139,417 170,566 212,941
Amortization of below-market leases (240,882) (345,948) (456,393) (169,363)
Straight-line rent adjustment (452,427) (660,705)    
Changes in operating assets and liabilities:        
Other assets 487,961 1,000,323 69,305 (1,170,342)
Accounts payable and accrued liabilities 267,164 (1,008,736) (1,392,693) 2,273,512
Accrued real estate taxes 29,155 (473,886) (82,780) 955,216
Net cash provided by operating activities 4,328,197 2,465,576 3,722,082 3,768,982
Cash flows from investing activities:        
Real estate acquisitions (16,810,985) (15,774,855) (23,667,535) (67,852,592)
Additions to buildings and tenant improvements (3,156,986) (3,713,626) (4,150,213) (2,854,939)
Additions to deferred leasing costs (407,653) (710,721) (931,199) (639,004)
Proceeds from sales of real estate 16,463,558 8,560,357 9,768,417 37,755,598
Restricted cash 416,678 2,992,873 2,488,138 (2,673,288)
Net cash used in investing activities (3,495,388) (8,645,972) (16,492,392) (36,264,225)
Cash flows from financing activities:        
Proceeds from mortgage notes payable, net of issuance costs 13,342,994 18,979,585 26,081,321 50,864,054
Repayment of mortgage notes payable (9,656,060) (9,217,047) (10,266,235) (30,834,664)
Series B preferred stock costs (153,500)      
Redemption of mandatorily redeemable preferred stock (2,000,000) (2,300,000) (2,300,000)  
Proceeds from issuance of mandatorily redeemable preferred stock, net of offering costs       18,200,000
Proceeds from issuance of common stock       49,999
Contributions from noncontrolling interests net of distributions paid 1,592,414 197,148 317,266 (493,534)
Repurchase of common stock (17,394) (55,023) (55,031) (176,461)
Dividends paid to stockholders (3,620,879) (3,347,690) (4,517,287) (4,123,730)
Net cash (used in) provided by financing activities (512,425) 4,256,973 9,260,034 33,485,664
Net increase (decrease) in cash and cash equivalents 320,384 (1,923,423) (3,510,276) 990,421
Cash and cash equivalents-beginning of period 3,116,147 6,626,423 6,626,423 5,636,002
Cash and cash equivalents-end of period 3,436,531 4,703,000 3,116,147 6,626,423
Supplemental disclosure of cash flow information:        
Interest paid Series B preferred stock 3,355,983 5,080,417 6,250,360 3,439,189
Interest paid-mortgage notes payable 5,441,424 5,449,481 7,244,413 5,965,824
Non-cash investing and financing activities:        
Reinvestment of cash dividends $ 1,095,434 1,795,040 2,364,387 2,661,979
Accrual of dividends payable   $ 1,155,498 $ 1,171,924 $ 1,063,454